(19)
(11)EP 2 842 555 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
15.04.2015 Bulletin 2015/16

(43)Date of publication A2:
04.03.2015 Bulletin 2015/10

(21)Application number: 14195394.3

(22)Date of filing:  04.12.2009
(51)Int. Cl.: 
A61K 31/201  (2006.01)
A61P 3/10  (2006.01)
A23L 1/30  (2006.01)
(84)Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30)Priority: 09.12.2008 ES 200803480

(62)Application number of the earlier application in accordance with Art. 76 EPC:
09831504.7 / 2374453

(71)Applicant: Universitat de les Illes Balears
07122 Palma de Mallorca (ES)

(72)Inventors:
  • Escribá Ruiz, Pablo Vicente
    07004 Illes Balears (ES)
  • Busquets Xaubet, Xavier
    07181 Illes Balears (ES)

(74)Representative: Illescas, Manuel 
Manuel Illescas y Asociados, S.L. (MIA) Principe de Vergara n° 197 Oficina 1°A
28002 Madrid
28002 Madrid (ES)

  


(54)Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines in the treatment of diabetes


(57) Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines.
The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use in the treatment of diabetes.